INPP5D and Hyperglycemia: The hyporesponsiveness to IL10 in the presence of high glucose appears linked to reduced intracellular signal transduction through STAT3, whereas the anti-inflammatory actions of AQX-MN100, a small molecule activator of SHIP1, is not affected by hyperglycemia.